跳至主要内容
临床试验/NCT04539834
NCT04539834已完成不适用

Electrolyte State in Patients With COVID-19

Zagazig University1 个研究点 分布在 1 个国家目标入组 983 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
983
试验地点
1
主要终点
electrolytes disturbances in patients with COVID-19

研究概览

简要总结

Initial case reports and cohort studies have described many clinical characteristics of patients with coronavirus disease 2019 (COVID-19), an emerging infectious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In early COVID-19 studies, some evidence has been provided that electrolyte disorders may also be present upon patients' presentation, including sodium, potassium, chloride and calcium abnormalities

the aim of the study is Identification of elements that affect COVID-19 pathology to improve survival and decrease mortality rate.

详细描述

SARS-CoV-2 invades human cells through binding angiotensin I converting enzyme 2 (ACE2) on the cell membrane. ACE2 is widely distributed in many types of human tissues, especially in the vital organs, such as heart, liver, kidney, and lungs. ACE2 is viewed as the principal counter-regulatory mechanism for the main axis of renin-angiotensin system (RAS) that is an essential player in the control of blood pressure and electrolyte balance. The final effect is to increase reabsorption of sodium and water, and thereafter increase blood pressure and excretion of potassium (K+). Besides, patients with COVID-19 often had gastrointestinal symptoms such as diarrhea and vomiting

Early studies proved that high percentage of COVID-19 patient were presented with electrolyte disorders, including sodium, potassium, chloride and calcium abnormalities. Such electrolyte disturbances have important implications not only for patient management but also for identifying potential pathophysiologic mechanisms underlying COVID-19 that could drive novel therapeutic opportunities

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years old who were confirmed by the real-time PCR on the respiratory tract samples as positive of SARS-CoV-2.

排除标准

  • Patients who had other causes of electrolyte disturbances (9):
  • Chronic organ dysfunction (e.g., hepatic or renal dysfunction),
  • Terminal cancer, immunodeficiency, and
  • Patients with a history of long-term use of hormones & Diuretics were excluded.

结局指标

主要结局

electrolytes disturbances in patients with COVID-19

时间窗: 4 months

Serum Electrolytes (Na, K, Ca, Cl, Ph, Mg) abnormality in COVID 19 patients laboratory results in the different stages of the disease

次要结局

  • To asses the relation of the electrolyte disturbances with the severity of COVID-19 infection.(4 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Essamedin Mamdouh Negm

lecturer

Zagazig University

研究点 (1)

Loading locations...

相似试验